Jonathan E. Kolitz - Concepedia

Author

Jonathan E. Kolitz

Also Known As

Bloomfield, Clara D., J E Kolitz, J Kolitz, J W Singer, J. E. Kolitz, J. Kolitz, J.E. Kolitz, Jonathan E Kolitz, Jonathan E. Kolitz, Jonathan Kolitz

471

Publications

24K

Citations

H-Index

111

Concepts

All Affiliations

The Ohio State University North Shore University Hospital Hofstra University Northwell Health University of Alabama at Birmingham

About

Jonathan E. Kolitz is an author at The Ohio State University specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	50	4.3K
2	Health Sciences	11	11	1.4K
3	Public Health	2	2	53
4	Engineering	1	1	53
5	Natural Sciences	1	1	151

Jonathan E. Kolitz

173

Publications

23.3K

Citations

H-Index

Page 1

	Year	Citations
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia Rajendra N. Damle, Tarun Wasil, Franco Fais, Blood	1999	2.6K
Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia R. Kanti, Bercedis L. Peterson, Frederick R. Appelbaum, New England Journal of Medicine	2000	1K
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia Jeffrey E. Lancet, Geoffrey L. Uy, Jörge E. Cortes, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaPharmacotherapyMetronomic ChemotherapyMyeloid NeoplasiaHematological Malignancy	2018	958
<i>IDH1</i> and <i>IDH2</i> Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Guido Marcucci, Kati Maharry, Yue-Zhong Wu, Journal of Clinical Oncology	2010	757
Adverse Prognostic Significance of <i>KIT</i> Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study Peter Paschka, Guido Marcucci, Amy S. Ruppert, Journal of Clinical Oncology	2006	660
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells Bradley T. Messmer, Davorka Messmer, Steven L. Allen, Journal of Clinical Investigation Mixed-phenotype Acute LeukemiaImmunologyPathologyBirth RatesCellular Physiology	2005	574
MicroRNA Expression in Cytogenetically Normal Acute Myeloid Leukemia Guido Marcucci, Michael D. Radmacher, Kati Maharry, New England Journal of Medicine	2008	437
Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia Bradley T. Messmer, Emilia Albesiano, Dimitar G. Efremov, The Journal of Experimental Medicine HistocompatibilityRegion RepertoireMultiple Distinct SetsImmunologyImmunodominance	2004	434
Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia Krzysztof Mrózek, Guido Marcucci, Deedra Nicolet, Journal of Clinical Oncology	2012	405
Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study Guido Marcucci, Krzysztof Mrózek, Amy S. Ruppert, Journal of Clinical Oncology	2005	381

Page 1